This article has expired, however you can still
download the PDF
NuvOx Pharma announces that the first patients have been dosed in a
Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being
developed for acute ischemic stroke. The trial is being performed at the
University of Arkan...